ABBOTT LABORATORIES - Common Stock (ABT)

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock
Shares outstanding
1,740,239,592
Number of holders
3,135
Total 13F shares, excl. options
1,348,790,206
Shares change
-303,300
Total reported value, excl. options
$178,801,336,976
Value change
+$458,110,755
Put/Call ratio
87%
Number of buys
1,361
Number of sells
1,453
Price
$132.65

Institutional Holders of ABBOTT LABORATORIES - Common Stock (ABT) as of Q1 2025

As of 31 Mar 2025 ABBOTT LABORATORIES - Common Stock (ABT) had 3,135 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 1,348,790,206 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., STATE STREET CORP, Capital International Investors, Capital Research Global Investors, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, WELLINGTON MANAGEMENT GROUP LLP, and NORTHERN TRUST CORP.
This table shows 3,140 institutional shareholders of the security as of 31 Mar 2025.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.